Fujifilm Irvine workforce cuts; Gates Foundation invests in Africa-made vaccines; Sharp acquires BSM

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls, and more.

This week we saw Fu­ji­film Irvine Sci­en­tif­ic lay off em­ploy­ees across its fa­cil­i­ties in Cal­i­for­nia, as well as the Gates Foun­da­tion in­vest­ing $40 mil­lion in vac­cines for low­er- and mid­dle-in­come coun­tries by lever­ag­ing Quan­toom Bio­sciences’ mR­NA tech.

We ze­ro in on mul­ti­ple builds, in­clud­ing eX­moor phar­ma’s new 65,000 square-foot cell and gene fa­cil­i­ty in Bris­tol, UK, as well as Chi­na-based Sino Bi­o­log­i­cal launch­ing its first fa­cil­i­ty in the US for re­com­bi­nant pro­tein pro­duc­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.